Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session

Published 19/10/2022, 17:30
Updated 19/10/2022, 18:40
© Reuters.  Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session

Gainers

  • SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
  • Scopus BioPharma Inc. (NASDAQ: SCPS) rose 66% to $0.4075. Scopus Biopharma completed recapitalization designed to enhance shareholder value.
  • RedHill Biopharma Ltd. (NASDAQ: RDHL) gained 61.6% to $0.75 after the company announced its oral broad-acting antiviral, Opaganib, was granted a new COVID-19 treatment patent.
  • Kintara Therapeutics, Inc. (NASDAQ: KTRA) jumped 40% to $0.1401. The company announced it paused its REM-001 program to conserve funds to support its VAL-083 international registrational study.
  • HV Bancorp, Inc. (NASDAQ: HVBC) climbed 29% to $25.87. Citizens Financial Services and HV Bancorp signed definitive merger agreement for $67.4 million.
  • Crown ElectroKinetics Corp. (NASDAQ: CRKN) gained 24.3% to $0.4000.
  • LMF Acquisition Opportunities, Inc. (NASDAQ: LMAO) shares gained 22.3% to $10.47 after the company announced stockholders approved the previously-announced business combination with SeaStar Medical.
  • Cabaletta Bio, Inc. (NASDAQ: CABA) surged 19% to $1.18. Cabaletta Bio CEO Steven Nichtberger reported purchase of 141,873 shares at an average price of $0.99 per share in Form 4 Filing on Tuesday.
  • SOBR Safe, Inc. (NASDAQ: SOBR) shares gained 17.6% to $3.1270 after the company announced it secured a large industrial customer and validation of its sales strategy.
  • Momentive Global Inc. (NASDAQ: MNTV) surged 16% to $7.54 following a Bloomberg report suggesting the company is considering a sale after receiving takeover interest.
  • SaverOne 2014 Ltd (NASDAQ: SVRE) jumped 16% to $1.67. SaverOne signed a memorandum of understanding with leading truck manufacturer, Iveco.
  • Gaucho Group Holdings, Inc. (NASDAQ: VINO) gained 16% to $0.3028.
  • Oblong, Inc. (NASDAQ: OBLG) rose 14.5% to $0.5151 after gaining 25% on Tuesday.
  • Netflix, Inc. (NASDAQ: NASDAQ:NFLX) rose 14% to $274.64 after the company reported better-than-expected Q3 results and reported global streaming paid net additions of 2.41 million. Global streaming paid memberships grew 4.5% year over year.
  • Zymeworks Inc. (NASDAQ: ZYME) gained 12.8% to $6.34 after the company and Jazz Pharmaceuticals announced an exclusive license agreement to develop and commercialize zanidatamab.
  • Intuitive Surgical, Inc. (NASDAQ: NASDAQ:ISRG) shares rose 11.4% to $215.88 as the company reported better-than-expected third-quarter adjusted EPS and sales results.
  • Waterdrop Inc. (NYSE: WDH) gained 8.8% to $1.23.
  • Interactive Brokers Group, Inc. (NASDAQ: IBKR) rose 6.2% to $75.58 following upbeat Q3 earnings.
  • United Airlines Holdings, Inc. (NASDAQ: UAL) rose 5.7% to $39.40 after the company reported better-than-expected Q3 results.
  • ASML Holding N.V. (NASDAQ: AS:ASML) rose 3.2% to $411.76 after reporting upbeat quarterly sales.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • Olaplex Holdings, Inc. (NASDAQ: OLPX) shares tumbled 50.4% to $4.8599 after the company issued Q3 and FY22 sales guidance below analyst estimates.
  • Sientra, Inc. (NASDAQ: SIEN) dipped 27.8% to $0.44 after the company announced a proposed public offering.
  • Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) dropped 23.7% to $0.6950. Advaxis and Ayala Pharmaceuticals entered into merger agreement in all-stock deal.
  • Gelesis Holdings, Inc. (NYSE: GLS) dipped 21.5% to $0.6239.
  • Generac Holdings Inc. (NYSE: GNRC) fell 19.8% to $118.49 after the company reported preliminary Q3 EPS results are lower year over year. The company also lowered its FY22 net sales growth guidance and net income margin.
  • mCloud Technologies Corp. (NASDAQ: MCLD) dropped 19.5% to $0.99.
  • EQRx, Inc. (NASDAQ: EQRX) fell 17.6% to $4.5350.
  • Establishment Labs Holdings Inc. (NASDAQ: ESTA) dropped 16.3% to $47.19. Hindenburg Research issued report on Establishment Labs titled 'A Financially Stretched Silicone Safety Charade.'
  • ProPhase Labs, Inc. (NASDAQ: PRPH) fell 13.8% to $9.36. ProPhase Labs announced collaboration with G42 Healthcare.
  • Horizon Global Corporation (NYSE: HZN) declined 13.6% to $0.6993.
  • EverCommerce Inc. (NASDAQ: EVCM) fell 13.1% to $8.25. Goldman Sachs (NYSE:GS) initiated coverage on EverCommerce with a Sell rating and announced a price target of $8.
  • Repligen Corporation (NASDAQ: RGEN) dropped 12.3% to $181.38.
  • M&T Bank Corporation (NYSE: MTB) fell 12.5% to $165.60 after the company reported worse-than-expected Q3 EPS results.
  • Eqonex Limited (NASDAQ: EQOS) shares fell 11.7% to $0.3109 after jumping 35% on Tuesday.
  • Winnebago Industries, Inc. (NYSE: WGO) dropped 10.8% to $53.64 following Q4 results.
  • Quanergy Systems, Inc. (NYSE: QNGY) fell 10.2% to $1.2659 after dipping 16% on Tuesday. Quanergy Systems recently announced a restructuring plan including an 11% staff reduction.
  • Kala Pharmaceuticals, Inc. (NASDAQ: KALA) fell 9.6% to $0.2421 after gaining around 8% on Tuesday. Kala Pharmaceuticals, during August, posted a Q2 loss of $0.38 per share.
  • The Vita Coco Company, Inc. (NASDAQ: COCO) dropped 9.1% to $10.68.
  • Insmed Incorporated (NASDAQ: INSM) dipped 9% to $20.03. Insmed announced strategic financings totaling $775 million.
  • Carvana Co. (NYSE: CVNA) fell 8.8% to $16.75. Wells Fargo (NYSE:WFC) maintained Carvana with an Equal-Weight and lowered the price target from $35 to $30.
  • THOR Industries, Inc. (NYSE: THO) dropped 7.4% to $75.29. Thor Industries Board of Directors recently approved a 5% increase in its quarterly dividend to $0.45 from $0.43.
  • Rubicon Technologies, Inc. (NASDAQ: RBT) shares fell 7.2% to $1.6150 after jumping 58% on Tuesday.
  • Abbott Laboratories (NYSE: NYSE:ABT) dropped 7.1% to $97.53 despite the company reporting better-than-expected Q3 EPS and sales results and raising guidance. The company's Q3 sales decreased 4.7% year over year.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.